Ado-trastuzumab emtansine Intravenous and Conjugated estrogens vaginal
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Conjugated estrogens vaginal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: conjugated estrogens topical
Brand name: Premarin Vaginal, Synthetic Conjugated Estrogens, A, Premarin Vaginal Cream, Synthetic Conjugated Estrogens-A
Synonyms: Conjugated estrogens (vaginal), Estrogens (Conjugated/Equine, Topical)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Conray
- Ado-trastuzumab emtansine Intravenous-Conray 30
- Ado-trastuzumab emtansine Intravenous-Conray 400
- Ado-trastuzumab emtansine Intravenous-Conray 43
- Ado-trastuzumab emtansine Intravenous-Consensi
- Ado-trastuzumab emtansine Intravenous-Constulose
- Conjugated estrogens vaginal-Adox Pak 2/100
- Conjugated estrogens vaginal-Adoxa
- Conjugated estrogens vaginal-Adoxa CK
- Conjugated estrogens vaginal-Adoxa Pak
- Conjugated estrogens vaginal-Adoxa Pak 1/100
- Conjugated estrogens vaginal-Adoxa Pak 1/150